182 related articles for article (PubMed ID: 36460712)
1. Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer.
Blaschke CRK; Hill EG; Mehta AS; Angel PM; Laronga C; Drake RR
Sci Rep; 2022 Dec; 12(1):20801. PubMed ID: 36460712
[TBL] [Abstract][Full Text] [Related]
2. Differential
Yaman ME; Kayili HM; Albayrak M; Kadioglu Y; Salih B
Mol Omics; 2021 Jun; 17(3):394-404. PubMed ID: 33735360
[TBL] [Abstract][Full Text] [Related]
3. Rapid N-Glycan Profiling of Serum and Plasma by a Novel Slide-Based Imaging Mass Spectrometry Workflow.
Blaschke CRK; Black AP; Mehta AS; Angel PM; Drake RR
J Am Soc Mass Spectrom; 2020 Dec; 31(12):2511-2520. PubMed ID: 32809822
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls.
Kawaguchi-Sakita N; Kaneshiro-Nakagawa K; Kawashima M; Sugimoto M; Tokiwa M; Suzuki E; Kajihara S; Fujita Y; Iwamoto S; Tanaka K; Toi M
Biochem Biophys Res Commun; 2016 Jan; 469(4):1140-5. PubMed ID: 26740182
[TBL] [Abstract][Full Text] [Related]
5. Alternations of N-glycans recognized by Phaseolus vulgaris leucoagglutinin in the saliva of patients with breast cancer.
Yang J; Ma T; Yu H; Yin M; Qiao Y; Niu L; Yang F; He J; Li Z
Neoplasma; 2021 Sep; 68(5):994-1004. PubMed ID: 34374293
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
[TBL] [Abstract][Full Text] [Related]
7. Tumor volume doubling time estimated from digital breast tomosynthesis mammograms distinguishes invasive breast cancers from benign lesions.
Sadeghipour N; Tseng J; Anderson K; Ayalasomayajula S; Kozlov A; Ikeda D; DeMartini W; Hori SS
Eur Radiol; 2023 Jan; 33(1):429-439. PubMed ID: 35779088
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
Lee SB; Bose S; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Lee K; Chang S; Park HS; Lee JW; Kim DC
PLoS One; 2020; 15(4):e0231004. PubMed ID: 32271809
[TBL] [Abstract][Full Text] [Related]
9. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
[TBL] [Abstract][Full Text] [Related]
11. Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease.
Grimm LJ; Miller MM; Thomas SM; Liu Y; Lo JY; Hwang ES; Hyslop T; Ryser MD
Radiology; 2019 Jul; 292(1):77-83. PubMed ID: 31112087
[TBL] [Abstract][Full Text] [Related]
12. A preliminary report on the role of spatial frequency analysis in the perception of breast cancers missed at mammography screening.
Mello-Thoms C; Chapman B
Acad Radiol; 2004 Aug; 11(8):894-908. PubMed ID: 15288040
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
14. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
Théberge I; Vandal N; Guertin MH; Perron L
Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
[TBL] [Abstract][Full Text] [Related]
15. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
16. Abnormal Galactosylated-Glycans recognized by Bandeiraea Simplicifolia Lectin I in saliva of patients with breast Cancer.
Yang J; Liu X; Shu J; Hou Y; Chen M; Yu H; Ma T; Du H; Zhang J; Qiao Y; He J; Niu L; Yang F; Li Z
Glycoconj J; 2020 Jun; 37(3):373-394. PubMed ID: 32103424
[TBL] [Abstract][Full Text] [Related]
17. A serum glycomics approach to breast cancer biomarkers.
Kirmiz C; Li B; An HJ; Clowers BH; Chew HK; Lam KS; Ferrige A; Alecio R; Borowsky AD; Sulaimon S; Lebrilla CB; Miyamoto S
Mol Cell Proteomics; 2007 Jan; 6(1):43-55. PubMed ID: 16847285
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans.
Park CW; Jo Y; Jo EJ
Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014
[TBL] [Abstract][Full Text] [Related]
19. Screening mammography-detected cancers: sensitivity of a computer-aided detection system applied to full-field digital mammograms.
Yang SK; Moon WK; Cho N; Park JS; Cha JH; Kim SM; Kim SJ; Im JG
Radiology; 2007 Jul; 244(1):104-11. PubMed ID: 17507722
[TBL] [Abstract][Full Text] [Related]
20. Altered N-linked glycosylation in endometrial cancer.
Mittal P; Briggs M; Klingler-Hoffmann M; Kaur G; Packer NH; Oehler MK; Hoffmann P
Anal Bioanal Chem; 2021 Apr; 413(10):2721-2733. PubMed ID: 33222001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
